4//SEC Filing
Varian John 4
Accession 0001104659-24-006392
CIK 0001390478other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:01 AM ET
Size
7.8 KB
Accession
0001104659-24-006392
Insider Transaction Report
Form 4
Varian John
Director
Transactions
- Award
Common Stock
2024-01-22+6,000→ 10,400 total - Award
Stock Option (Right to Buy)
2024-01-22+10,000→ 10,000 totalExercise: $0.52Exp: 2034-01-22→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
- [F2]The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001416176
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 6:01 AM ET
- Size
- 7.8 KB